BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Genetown

  Boston Scientific Corporation’s SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)

  May 19, 2008

   · 

  5 min read
• Drug Development

  Pharmacopeia Drug Discovery’s First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients

  May 19, 2008

   · 

  10 min read
• Drug Development

  Ardea Biosciences, Inc. Identifies Lead Development Candidate for Gout, RDEA594

  May 19, 2008

   · 

  5 min read
• Pharm Country

  Aureon Laboratories Introduces Prostate Px(R)+, First Biopsy-Based Test to Predict Prostate Cancer Disease Progression and Recurrence

  May 19, 2008

   · 

  1 min read
• Business

  Cortex Pharmaceuticals, Inc. Announces Mark Varney to Become President and Chief Executive Officer

  May 19, 2008

   · 

  5 min read
• Bio NC

  PhytoPharmacon Strengthens Intellectual Property Position

  May 19, 2008

   · 

  1 min read
• Pharm Country

  Regeneron Pharmaceuticals, Inc. Announces Presentation at Citi Investment Research Global Healthcare Conference

  May 19, 2008

   · 

  1 min read
• Frost & Sullivan Release: Tremendous Potential for Fibromyalgia Pharmaceuticals in Europe

  May 19, 2008

   · 

  1 min read
• Drug Development

  Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent

  May 19, 2008

   · 

  2 min read
• Pharm Country

  University of Connecticut Health Center and Competitive Technologies, Inc. Announce National Institutes of Health (NIH) Grant for Asthma Study

  May 19, 2008

   · 

  1 min read